About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Portland | 178 Studies

Clinical Trials Colorectal CancerPortland

Colorectal Cancer Clinical Trials in Portland

Find 178 clinical trials for colorectal cancer near Portland, Oregon. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Portland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 178 trials

TerminatedPh 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular CarcinomaPhase 1: Assessment of safety and tolerability of ADI-PEG 20 in combination with folinic acid (leucovorin), fluorouracil and oxaliplatin (FOLFOX) in advanced GI malignancies.NCT02102022·San Francisco, California and 34 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedSurgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00023751·Anniston, Alabama and 179 others

RecruitingA Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received ChemotherapyThe purpose of this study is to compare how long the participants are disease-free (progression-free survival) and and the length of time until a participant dies (overall…NCT06750094·Chandler, Arizona and 250 others

Active not recruitingPhase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid TumorThis study is open to adult patients with solid tumors who have a KRAS G12V mutation.NCT06105021·Los Angeles, California and 9 others

RecruitingA Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of DiseaseColorectal cancer (CRC) is the third most common type of cancer diagnosed worldwide.NCT07023289·Huntsville, Alabama and 47 others

RecruitingColonoscopy vs Stool Testing for Older Adults With Colon PolypsThis is a multi-site comparative effectiveness randomized controlled trial (RCT) comparing annual fecal immunochemical testing (FIT) and colonoscopy for post-polypectomy…NCT05612347·Birmingham, Alabama and 23 others

RecruitingA Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)This is an open-label multicenter, single-arm Phase II study of Fruquintinib in combination with FOLFIRI (leucovorin calcium (folinic acid), fluorouracil, and irinotecan) in…NCT07011576·Denver, Colorado and 13 others

CompletedA Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)The purpose of this study is to assess the safety and efficacy of coformulated favezelimab/pembrolizumab (MK-4280A) in participants with metastatic colorectal cancer.NCT05064059·Washington D.C., District of Columbia and 151 others

CompletedFocusing Implementation to Bring Effective Reminders (FIBER)FIBER is 4-year study that will evaluate the implementation of a large-scale population-based colorectal cancer screening patient reminder and coordinated follow-up program.NCT00656838·Portland, Oregon

CompletedIrinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00012389·Huntsville, Alabama and 153 others

CompletedCetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerPURPOSE: This randomized phase III trial is studying cetuximab and/or bevacizumab when given together with combination chemotherapy to compare how well they work in treating…NCT00265850·Mobile, Alabama and 682 others

TerminatedA Phase 1 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK PathwayThis is a Phase 1, open-label, multicenter, study evaluating the safety, tolerability, PK, PD, and anti-tumor activity of MRTX0902 alone and in combination with MRTX849…NCT05578092·New Haven, Connecticut and 17 others

Active not recruitingDuloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal CancerThis phase II/III trial studies the best dose of duloxetine and how well it works in preventing pain, tingling, and numbness (peripheral neuropathy) caused by treatment with…NCT04137107·Birmingham, Alabama and 792 others

CompletedOpen-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal CancerThe objective of this trial is to evaluate the safety and tolerability of BI 695502 in combination with leucovorin/5-fluorouracil/oxaliplatin (mFOLFOX6) and as maintenance therapy…NCT02776683·Phoenix, Arizona and 45 others

CompletedA Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line TherapyThe objective of this study is to compare the progression free survival (PFS), overall survival (OS), objective response rate (ORR), time to treatment failure (TTF), duration of…NCT01478594·Gilbert, Arizona and 72 others

CompletedS1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal CancerThis clinical trial studies the use of the financial impact assessment tool in patients with colorectal cancer that has spread from the primary site to other places in the body.NCT02728804·Anchorage, Alaska and 536 others

CompletedS1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal CancerThis randomized phase II trial studies how well irinotecan hydrochloride and cetuximab with or without vemurafenib works in treating patients with colorectal cancer that has…NCT02164916·Anchorage, Alaska and 762 others

RecruitingA Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H MutationPhase I Study of NT-175, an autologous T cell therapy product genetically engineered to express an HLA-A\*02:01-restricted T cell receptor (TCR), targeting TP53 R175H mutant…NCT05877599·Gilbert, Arizona and 22 others

CompletedStrategies and Opportunities to Stop Colon Cancer in Priority PopulationsOnly an estimated 50 million US adults aged 50-75 are up-to-date on colorectal cancer (CRC) screening according to guidelines set by the federal government.NCT01742065·Arcata, California and 7 others

CompletedTranslation of Colorectal Cancer Screening Guidelines to Practice: A System InterventionColorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States.NCT00122187·Phoenix, Arizona and 8 others

PreviousPage 2 of 9Next

Other Conditions in Portland

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma